A number of papers published in 2018 have provided important information expected to influence clinical practice, particularly for the management of functional mitral regurgitation in patients with heart failure caused by ischaemic or non-ischaemic cardiomyopathy and for the treatment of severe aortic stenosis in patients at low surgical risk.
Key advances
-
Functional mitral regurgitation (MR) should not be regarded merely as a marker of severity of heart failure (HF), but also as having an active role in the progression of HF1.
-
The most relevant adverse prognostic effect of severe MR seems to be in a subcohort of patients with intermediate HF phenotype; in patients with advanced remodelling, functional MR is no longer of prognostic relevance1.
-
The results of the MITRA-FR and COAPT trials should be interpreted as being complementary rather than contradictory2,3.
-
The prognostic benefit of the MitraClip procedure is clearly apparent in patients with moderate-to-severe or severe MR in whom the left ventricle is not too dilated2,3.
-
In patients at low surgical risk with severe aortic stenosis, TAVR seems to be associated with increased mortality; SAVR should for now remain the treatment of choice for these patients4.
References
Goliasch, G. et al. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur. Heart J. 39, 39–46 (2018).
Obadia, J. F. et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1805374 (2018).
Stone, G. W. et al. Transcatheter mitral valve repair in patients with heart failure. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1806640 (2018).
Witberg, G. et al. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: a meta-analysis of randomized trials and propensity score matched observational studies. Catheter. Cardiovasc. Interv. 92, 408–416 (2018).
Acknowledgements
The author thanks Davide Schiavi (Alfieri Heart Foundation, Milan, Italy) for the help provided.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Alfieri, O. Informed decision-making in patients with valvular disease. Nat Rev Cardiol 16, 81–82 (2019). https://doi.org/10.1038/s41569-018-0146-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-018-0146-1
- Springer Nature Limited